ConductScience.org, home

Paper42226151

CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy.

Huang M and 5 others. BMC Vet Res, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy. Papers, record 42226151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226151

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy.
PubMed
Journal
BMC Vet Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang MMianlong
2Li XXiufang
3Pan TTaian
4Wu DDonghai
5Li GGonghe
6Wu WWende

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Streptococcus agalactiaeMajor topic
Fish DiseasesMajor topic
Streptococcal InfectionsMajor topic
TilapiaMajor topic
CRISPR-Cas SystemsMajor topic
Streptococcal VaccinesMajor topic
Animals

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AB22013007the Fangchenggang Science and Technology ProgramPubMed
AA17204081-1Guangxi Science and Technology ProgramPubMed

Source PubMed

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,717,322Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings.Fish Shellfish Immunol2020https://conductscience.org/library/papers/32717322PubMed
240,689,231Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium stationis and its application in hypoxanthine biosynthesis.Synth Syst Biotechnol2025https://conductscience.org/library/papers/40689231PubMed
336,822,292Characterization and evaluation of an oral vaccine via nano-carrier for surface immunogenic protein (Sip) delivery against Streptococcus agalactiae infection.Int J Biol Macromol2023https://conductscience.org/library/papers/36822292PubMed
421,414,351Advances in fish vaccine delivery.Dev Comp Immunol2011https://conductscience.org/library/papers/21414351PubMed
538,493,985Biology and functions of fish thrombocytes: A review.Fish Shellfish Immunol2024https://conductscience.org/library/papers/38493985PubMed
617,394,525Evaluation of the link between gyrodactylosis and streptococcosis of Nile tilapia, Oreochromis niloticus (L.).J Fish Dis2007https://conductscience.org/library/papers/17394525PubMed
738,184,180Immune response and protective efficacy of Streptococcus agalactiae vaccine coated with chitosan oligosaccharide for different immunization strategy in nile tilapia (Oreochromis niloticus).Fish Shellfish Immunol2024https://conductscience.org/library/papers/38184180PubMed
826,139,332Microbiota metabolite regulation of host immune homeostasis: a mechanistic missing link.Curr Allergy Asthma Rep2015https://conductscience.org/library/papers/26139332PubMed
922,745,249A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.Science2012https://conductscience.org/library/papers/22745249PubMed
1031,374,315Development of an attenuated oral vaccine strain of tilapia Group B Streptococci serotype Ia by gene knockout technology.Fish Shellfish Immunol2019https://conductscience.org/library/papers/31374315PubMed
1124,011,059Transformation of chemically competent E. coli.Methods Enzymol2013https://conductscience.org/library/papers/24011059PubMed
1234,816,409Testing Novel Inactivation Methods and Adjuvants for Vaccines Against Streptococcus agalactiae in Nile Tilapia Oreochromis niloticus.Methods Mol Biol2022https://conductscience.org/library/papers/34816409PubMed
1332,970,777Determination of a novel parvovirus pathogen associated with massive mortality in adult tilapia.PLoS Pathog2020https://conductscience.org/library/papers/32970777PubMed
1437,798,358An expanded CRISPR-Cas9-assisted recombineering toolkit for engineering genetically intractable Pseudomonas aeruginosa isolates.Nat Protoc2023https://conductscience.org/library/papers/37798358PubMed
1539,833,194Engineered CRISPR-Cas9 for Streptomyces sp. genome editing to improve specialized metabolite production.Nat Commun2025https://conductscience.org/library/papers/39833194PubMed
1631,953,479Novel Chimeric Multiepitope Vaccine for Streptococcosis Disease in Nile Tilapia (Oreochromis niloticus Linn.).Sci Rep2020https://conductscience.org/library/papers/31953479PubMed
1739,561,912Survival, serum biochemical parameters, hepatic antioxidant status, and gene expression of three Nile tilapia strains under pathogenic Streptococcus agalactiae challenge.Fish Shellfish Immunol2024https://conductscience.org/library/papers/39561912PubMed
1836,717,067Comparative study of the effects of Montanide™ ISA 763A VG and ISA 763B VG adjuvants on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).Fish Shellfish Immunol2023https://conductscience.org/library/papers/36717067PubMed
1941,072,832IL-11 acts as a vaccine adjuvant in Nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae, enhancing both cellular and humoral immune responses.Fish Shellfish Immunol2026https://conductscience.org/library/papers/41072832PubMed
2031,751,658An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).Fish Shellfish Immunol2020https://conductscience.org/library/papers/31751658PubMed

See all 35 references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42226151

GET https://conductscience.org/api/papers/v1/42226151/references?page=2